2024-17935. Supplemental Evidence and Data Request on Environmental, Clinical and Economic Outcomes of Hospital Resources To Prevent Hospital-Acquired Infections  

  • PICOTS (Populations, Interventions, Comparators, Outcomes, Timing, and Setting) Inclusion and Exclusion Criteria

    Category Inclusion criteria Exclusion criteria
    Population Primary: Individuals receiving acute medical care Secondary: Healthcare workers using or caring for devices used in patient care Individuals receiving ambulatory care.
    Interventions Primary interest: Devices/items that are intended to prevent infection or are used for general bedside care, including but not limited to PPE, drapes, linens, laryngoscopes, blood pressure cuffs, pulse oximeters Secondary interest: Other devices/items used during hospital care, including but not limited to: surgical devices, other scopes Regulatory status: All devices/items must be either Devices/items with minimal or no pathogen transmission risk. Devices/items primarily used in an ambulatory or non-acute-care setting. Devices/items that have been reprocessed under emergency use authorization only. Implantable devices other than catheters.
    • FDA approved as reusable, and reprocessed per specifications
    OR
    • Designated as single-use, FDA authorized for reprocessing, and reprocessed per specifications
    Comparators Devices/items that are approved as single-use and are discarded after one use Single-use devices/items for which no reusable or authorized reprocessed alternatives are available in the US.
    Outcomes Health outcomes (Patient-level or aggregated patient data) Outcomes include but are not limited to: HAI, SSI, or pathogen transmission (including MDRO; Sepsis; ICU stay related to HAI; Length of stay; Mortality; Adverse effects; Healthcare worker infection or injury Quality of reprocessing. Usability by healthcare workers or patients. Device/item preferences of healthcare workers or patients. Device/item availability. Bacterial colonization of device/item.
    Economic outcomes (Hospital/health system perspective) Outcomes include but are not limited to: Procurement cost; Cost per procedure/use; Costs for: reprocessing, transportation, storage, functionality testing, maintenance, repair, disposal, replacement; Supply chain implications
    Environmental outcomes
    a. Environmental impact
    (Global, national, or regional perspective)
    Outcomes include but are not limited to: Greenhouse gas emissions; Air pollution; Water use; Water contamination; Energy use; Chemical use and toxicity; Recycling volume; Landfill use; Carcinogenic exposure; Climate change; Raw material extraction and processing
    b. Environmental health
    (Population health perspective)
    Outcomes include but are not limited to: Respiratory illness; Cardiovascular disease; Cancer risk; Infectious disease outbreaks
    Timing Any NA.
    Setting Acute care hospitals in countries rated “very high” on the 2021 Human Development Index (as defined by the United Nations Development Programme) * Non-hospital settings. Other countries.
    Publication type English language For primary interest interventions (devices/items used to prevent infections or for general bedside care): SRs, randomized controlled trials, nonrandomized controlled studies Non-English-language, abstracts, case reports, non-comparative studies, narrative reviews, commentaries, guidelines.
    For secondary interest interventions (other devices/items used for hospital care): SRs
    FDA: Food and Drug Administration; HAI: Healthcare-associated infection; ICU: Intensive care unit; MDRO: Multi-drug resistant organism; NA: Not applicable; PPE: Personal protective equipment; SR: Systematic review; SSI: Surgical site infection; US: United States.
    * Human development index. United Nations Development Programme. Accessed April 16, 2024. https://hdr.undp.org/​data-center/​human-development-index#/​indicies/​HDI.

Document Information

Published:
08/13/2024
Department:
Agency for Healthcare Research and Quality
Entry Type:
Notice
Action:
Request for supplemental evidence and data submission.
Document Number:
2024-17935
Dates:
Submission Deadline on or before September 12, 2024.
Pages:
65911-65912 (2 pages)
PDF File:
2024-17935.pdf